- Home
- Mutual Funds
- Nippon India Mutual Fund
- Nippon India Pharma Fund Direct-Growth
Fund Overview of Nippon India Pharma Fund Direct-Growth
-
₹9,166.4 CrAUM
-
₹640.95NAV
-
0.99%Expense Ratio
-
EquityFund Category
As on Thu Nov 05, 2026
Calculate your Returns
How much do you want to invest monthly?
₹
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
The total value of your investment
after 10 years will be
₹ 1,39,328.64
Nippon India Pharma Fund Direct-Growth Return Comparison
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -0.10% | NA | 6.12% |
| 6 Months | 9.28% | NA | 12.92% |
| 1 Year | 10.92% | 10.92% | 6.04% |
| 2 Years | 13.04% | 6.32% | 24.93% |
| 3 Years | 68.34% | 18.96% | 25.71% |
| 5 Years | 97.57% | 14.59% | 19.91% |
| 7 Years | 308.13% | 22.25% | NA |
| 10 Years | 344.38% | 16.08% | 12.78% |
View More
As on Thu Nov 05, 2026
Asset Allocation of Nippon India Pharma Fund Direct-Growth
equities
97.99%debt instruments
0.01%other assets or cash equivalents
2.00%Large Cap: 30.53%
Mid Cap: 40.10%
Small Cap: 29.37%
Other: 0.00%
Detailed Portfolio Analysis
As on Thu Nov 05, 2026
Invest Now
Nippon India Pharma Fund Direct-Growth is one Equity mutual fund offered by Nippon India Mutual Fund. Launched on 01 Jan 2013, the fund aims Long term capital growth. Investment in equity and equity related Securities of pharma & other associated companies. It manages assets worth ₹9,166.4 crore as on Wed Sep 30, 2026. The expense ratio stands at 0.99%. Fund Manager Manager Education
About FundAbout Nippon India Pharma Fund Direct-Growth
The portfolio allocation consists of 97.99% in equities, 0.01% in debt instruments, 2.00% in other assets or cash equivalents.Managed by Sailesh Raj Bhan, it has delivered a return of 10.92% in the last year, a total return since inception of 17.36%.
Identifying the right best sip plays a vital role for long-term wealth creation.
Sailesh Raj Bhan
Mr. Bhan is an MBA (Finance) and CFA.
Key Metrics of Nippon India Pharma Fund Direct-Growth
-
Standard Deviation14.87%
-
Mean18.37%
-
Sharpe Ratio0.86%
-
Alpha-2.14%
-
Beta0.89%
-
Sortino Ratio1.30%
Nippon India Pharma Fund Direct-Growth Fund Details
|
|
Compare Mutual Funds
Nippon India Pharma Fund Direct-Growth Fund Returns Comparison
Compare Nippon India Pharma Fund Direct-Growth with other mutual funds in the same category
Nippon India Pharma Fund Direct-Growth
SBI Healthcare Opportunities Fund Direct Plan-Growth
SBI Healthcare Opportunities Fund Direct Plan-IDCW
Compare more funds
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
SBI Healthcare Opportunities Fund Direct Plan-Growth  |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| SBI Healthcare Opportunities Fund-IDCW |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| Mirae Asset Healthcare Fund Direct-Growth |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| UTI Healthcare Fund Direct-Growth |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
| UTI Healthcare Fund Direct-IDCW |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
View More
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Nippon India Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Nippon India Pharma Fund-Growth
|
₹9,166 | 3.09% | -0.31% | 8.81% | 9.96% | 17.90% |
|
Nippon India Pharma Fund Direct-IDCW
|
₹9,166 | 3.16% | -0.10% | 9.28% | 10.92% | 18.96% |
|
Nippon India Pharma Fund-IDCW
|
₹9,166 | 3.09% | -0.31% | 8.81% | 9.96% | 17.90% |
|
Nippon India Nifty Pharma ETF-Growth
|
₹1,736 | 5.69% | 3.91% | 17.40% | 24.05% | 23.30% |
growth is based on 1-month returns of the fundsNippon India Pharma Fund Direct-Growth Calculator
I want to invest
Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for
Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
Expected return
Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Total Investment
Wealth Gained
Total Wealth
I want to save
I want to invest for
Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
Expected return
Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Total Investment
Wealth Gained
Monthly Investment
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth |
₹9,166 | ₹568.91 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-Growth |
₹9,166 | ₹640.95 | 18.96% | 14.59% | 16.08% |
| Nippon India Pharma Fund-IDCW |
₹9,166 | ₹122.85 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-IDCW |
₹9,166 | ₹175.42 | 18.96% | 14.59% | 16.08% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | ₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-Growth |
₹6,861 | ₹43.25 | 21.69% | 16.18% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | ₹26.43 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-IDCW |
₹6,861 | ₹23.23 | 21.69% | 16.18% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | ₹522.56 | 24.17% | 18.45% | 14.48% |
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹5,870 | ₹606.22 | 25.46% | 19.69% | 15.73% |
View More
Top funds are based on Fund AUM
Nippon India Pharma Fund Direct-Growth Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.85% | ₹1,158.46 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.35% | ₹1,152.63 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.55% | ₹1,145.91 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.92% | ₹1,099.37 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.08% | ₹1,086.73 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.02% | ₹1,075.90 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.71% | ₹1,072.95 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.71% | ₹1,072.95 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.71% | ₹1,072.95 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.22% | ₹1,067.77 Cr |
View More
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹606.22 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹421.18 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹522.56 | 24.17% | 18.45% | - |
| SBI Healthcare Opportunities Fund-IDCW |
₹329.19 | 24.17% | 18.45% | - |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹26.43 | 22.70% | 17.19% | - |
| Mirae Asset Healthcare Fund Direct-Growth |
₹53.16 | 24.58% | 17.02% | - |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹32.02 | 24.58% | 17.02% | - |
| UTI Healthcare Fund Direct-Growth |
₹388.33 | 24.39% | 16.87% | - |
| UTI Healthcare Fund Direct-IDCW |
₹300.15 | 24.39% | 16.87% | - |
View More
growth is based on 5Y returns of the funds
Frequently Asked Questions
Nippon India Pharma Fund Direct-Growth
What is the current AUM of Nippon India Pharma Fund Direct-Growth?
As of Wed Sep 30, 2026, Nippon India Pharma Fund Direct-Growth manages assets worth ₹9,166.4 crore
How has Nippon India Pharma Fund Direct-Growth performed recently?
- 3 Months: -0.10%
- 6 Months: 9.28%
What is the long-term performance of Nippon India Pharma Fund Direct-Growth?
- 3 Years CAGR: 18.96%
- 5 Years CAGR: 14.59%
- Since Inception: 17.36%
What is the portfolio composition of Nippon India Pharma Fund Direct-Growth?
Equity: 97.99%, Debt: 0.01%, Others: 2.00%.
Who manages Nippon India Pharma Fund Direct-Growth?
Nippon India Pharma Fund Direct-Growth is managed by Sailesh Raj Bhan from Nippon India Mutual Fund.
What is the market-cap allocation of Nippon India Pharma Fund Direct-Growth?
Large Cap: 30.53%, Mid Cap: 40.10%, Small Cap: 29.37%.
Which are the top companies Nippon India Pharma Fund Direct-Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
Which are the major sectors Nippon India Pharma Fund Direct-Growth focuses on?
- Healthcare – 253.46% of the fund's portfolio
View more FAQ's
